JCDR - Register at Journal of Clinical and Diagnostic Research
Journal of Clinical and Diagnostic Research, ISSN - 0973 - 709X
Surgery Section DOI : 10.7860/JCDR/2016/16736.7417
Year : 2016 | Month : Mar | Volume : 10 | Issue : 03 Full Version Page : PC10 - PC15

Quality of Life after Frey’s Procedure in Patients with Chronic Pancreatitis

Satyajit Rath1, Susanta Meher2, Abhimanyu Basu3, Sujata Priyadarshini4, Bikram Rout5, Rakesh Sharma6

1 Senior Resident, Department of General Surgery, AIIMS, Bhubaneswar, Odisa, India.
2 Senior Resident, Department of General Surgery, AIIMS, Bhubaneswar. Odisa, India.
3 Professor, Department of General Surgery, Institute of Post Graduate Medical Education and Research, Kolkata, India.
4 Junior Consultant, Department of Anaesthesia, AMRI Hospital, Bhubaneswar, Odisa, India.
5 Senior Resident, Department of General Surgery, AIIMS, Bhubaneswar, Odisa, India.
6 Senior Resident, Department of General Surgery, AIIMS, Bhubaneswar, Odisa, India.


NAME, ADDRESS, E-MAIL ID OF THE CORRESPONDING AUTHOR: Dr. Susanta Meher, 1st Floor, Plot No 518/18, Sambit Villa, Ghatikia, Bhubaneswar, Khurdha-751003, Odisha, India.
E-mail: chikusus@gmail.com
Abstract

Introduction

Chronic pancreatitis is a debilitating disease, associated with excruciating abdominal pain, exocrine and endocrine pancreatic insufficiency. Different types of surgical techniques have been described for the management of complications of this disease. The most common procedure which has been adopted for improving the quality of life of the patients with chronic pancreatitis is Frey’s Procedure. It is an organ preserving procedure in which the main pancreatic duct is drained by lateral pancreatico-jejunostomy along with coring of the head of the pancreas.

Aim

In this study, we have assessed the outcome of Frey’s procedure in terms of quality of life in patients with chronic pancreatitis.

Materials and Methods

This was a prospective observational study done at a tertiary care center in West Bengal, India. The study period was from 2010 to 2014. All the patients who have undergone Frey’s Procedure during the study duration and with the postoperative histopathology of chronic pancreatitis were included in this study. The preoperative and postoperative pain and quality of life assessment was done using VAS score (0-100) and EORTC QLQ-C30 (Version 3) respectively. The statistical analysis was performed with the help of Epi Info (TM) 3.5.3.

Results

A total of 35 patients with chronic pancreatitis underwent Frey’s procedure during the study period. The mean age (mean ± s.e) of the 33 patients included in the study was 38.48±5.55 years with a range of 29-49 years. The mean preoperative Physical Functional Domain (PFD), Physical Domain (PD), Emotional Domain (ED), Social Domain (SD) and general health raw score with standard errors were 32.06±0.40, 37.86±0.36, 15.18±0.32, 8.63±0.31 and 4.48±0.26 respectively. ANOVA showed that there was significant differences in PFD, PD, ED, SD and GH values during different time period of follow up (p<0.0001) and as per Critical Difference the postoperative values of PFD, PD, ED and SD decreased while postoperative value of GH increased significantly in different months compared to the preoperative values.

Conclusion

We conclude that Frey’s procedure is a low risk surgery, which significantly improves the quality of life of the patients with chronic pancreatitis in all the domains and can be recommended as a surgical therapy for such patients.

Keywords

Introduction

Chronic pancreatitis (CP) is a progressive inflammatory disease of the pancreas characterized by debilitating pain and pancreatic exocrine and endocrine insufficiency [1]. Chronic alcohol abuse is the most common cause of chronic pancreatitis in western countries, accounting for about 60% CPs [2]. The incidence of CP is approximately 5-10 cases per 100,000 populations and has nearly quadrupled in the past 30 years, although this may be due to improvement in imaging technology rather than a true increase in occurrence [3,4]. India has the highest incidence of chronic pancreatitis in the world at approximately 114-200 cases per 100,000 persons [2]. But in India, tropical pancreatitis is the most frequently seen etiology of chronic pancreatitis. It is often classified as idiopathic but in fact it may have a mixed etiology, including metabolic, nutritional and genetic [3]. Approximately 90% of patients with CP complain of pain which requires multiple hospitalizations and that can lead to narcotic dependency [5]. The poor understanding of the disease pathology and unpredictable clinical course of the disease has made the management of patients suffering, difficult and challenging. Many studies have shown that CP has a substantial impact on quality of life because of chronic pain, and complications, including exocrine and endocrine insufficiency [68].

Previous studies have shown that 40% to 75% of patients with CP ultimately requires surgical intervention despite of medical and endoscopic intervention [9,10]. It is primarily used as the last step of the step up approach. But recent studies have showed benefits of early surgery on control of pain and preservation of exocrine and endocrine insufficiency before the disease progress into an irreversible stage. The main indication for surgery is intractable abdominal pain not relieved with medication, development of jaundice due to peri-choledochal inflammation and suspicion of malignancy [3,11]. Varied morphology of the gland, presence of inflammation in the pancreas and peri-pancreatic tissue, disease location, prior treatment and suspicion of malignancy has led to evolution of diverse resection and drainage procedures. 18-50% of patients with CP have disease limited to the head of the pancreas and resection is necessary for pain relief [12]. Pancreaticoduodenectomy may provide good pain relief, but there has been increasing enthusiasm for duodenum preserving pancreatic head resection along with ductal drainage procedures [13]. Two such procedures have gained importance; they are Beger’s procedure and Frey’s procedure [14]. Frey’s procedure is more popular among pancreatic surgeons as it avoids pancreatic neck resection and requires single anastomosis [15]. This novel technique was first described by Frey and Smith in 1987 which consist of local pancreatic head resection combined with longitudinal pancreatico-jejunostomy (LR-LPJ) [16].

CP is an incurable disease; the main purpose of any therapeutic intervention in CP is to make the patient pain free and improve the quality of life [17]. Several studies have shown that Frey’s procedure is an effective way for management of patients with intractable abdominal pain due to CP, which is associated with minimal morbidity and mortality and have a better quality of life after the procedure [1823].

Aim

In this study, we have intended to further validate the above theory and see whether Frey’s procedure is effective in Indian patients. The primary aim of this study was to observe and analyze the outcomes of Frey’s procedure on quality of life in patients with chronic pancreatitis. This study also deals with the clinical presentation, duration of surgery, particularly in relation to the diameter of pancreatic duct and peri-operative morbidity and mortality.

Materials and Methods

This was a prospective observational study done in Institute of Post Graduate Medical Education and Research, Kolkata, India, between 2010 and 2014. Ethical clearance was taken from the institutional review board for this study. Informed and written consent were taken from all patients. All proven cases of CP with age above 12 years having a main pancreatic duct diameter of ≥6.5mm with or without duct calculi and complaining of pain not controlled on medications were included in the study. Those patients with gross cardiovascular morbidity, splenomegaly and pancreatic malignancy in the postoperative histopathology were excluded from the study.

Demographic data were collected from all patients at the time of admission, including age sex, and BMI, history of alcohol intake, clinical presentation and main pancreatic duct diameter (MPD). Visual analogue scale (0-100) was used to assess the preoperative and postoperative pain [24]. Preoperative physical quality of life was assessed using European Organization for Research and Treatment of cancer (EORTC) QLQ-C30 (version 3) questionnaire (Appendix 1). This questionnaire was developed by the EORTC study group to use this as an instrument for quality of life assessment in cancer patients. It consists of 30 questions related to health related quality of life. In our study we have classified all the 30 questions into five domain i.e. Physical Function Domain (PFD), Physical Domain (PD), Emotional Domain (ED), Social Domain (SD) and Global Health (GH) to make the analysis and interpretation easy and simple (Appendix 2).

Total score of VAS and each domain was calculated in the preoperative period before surgery. Frey’s procedure was performed (coring of pancreatic head and longitudinal pancreaticojejunostomy) in all patients and tissues from the pancreatic head were sent for histopathological examination. Patients with evidence of malignancy on histopathology were excluded from the study. Postsurgery, patients were followed up after three months, then every six monthly for a period of three years. During each follow up patients were interviewed and physical quality of life was assessed using the same EORTC QLQ-C30(3) questionnaire [25] and VAS score. As we were using the raw scores for the comparison, a high score in the PFD, ED, SD and PD represents a low level of functioning or low level of symptomatology, while a low score in these domains represents a high level of functioning or high level of symptomatology. But a high score in global health domain (GH) represents a high quality of life (Qol) and a low score represents a low Qol.

Statistical Analysis

Statistical Analysis was performed with help of Epi Info (TM) 3.5.3. EPI INFO is a trademark of the Centers for Disease Control and Prevention (CDC). Descriptive statistical analysis was performed to calculate the means with corresponding standard errors (s.e) and the medians. Pearson correlation coefficient was used to assess the correlation between main pancreatic duct diameter and operative time. Analysis of variance (ANOVA) followed by Tukey’s Test was performed with the help of Critical Difference (CD) or Least Significant Difference (LSD) at 5% and 1% level of significance to compare the mean values. The p-value <0.05 was taken to be statistically significant.

Results

A total of 35 patients with features of CP underwent Frey’s procedure during the study period. Two patients with features of malignancy in the postoperative histopathology were excluded from the study. A total of 33 patients with features of CP in the postoperative histopathology were included in the study. Mean age of presentation was 38.48±5.55 years (29-49 years) and the median age was 38 years. Most of the patients were in the age group of 35-44 years (51.5%) compared to other age groups. Incidence among males (81.8%) was significantly higher than females. In our study non alcoholic patients (69.7%) were more commonly affected than alcoholic patients. Most of the patients were thin build with a BMI of < 19 kg/m2 (60.6%). The clinical and socio-demographic characteristics of the patients are shown in [Table/Fig-1].

Patients characteristics.

NumberPercentage (%)
Age (In years)
25-341030.3
35-441751.5
45 and above618.2
Gender
Male2781.8
Female618.2
Cause
Alcoholic1030.3
Non Alcoholic2369.7
Preoperative BMI (kg/m2)
16.1-192060.6
19.1-22927.3
22.1-25412.1
>2500
Complains at Presentation
Pain33100
Diabetes515.1
Diarrhea (Steatorrhea)824.2
Postoperative complications
Wound infections26.0
Abdominal abscess13.0
Pancreatic leak13.0
Total412.1

BMI: Body Mass Index


The mean MPD of the patients were 10.73±4.60mm with the range of 6.7-30mm and the median MPD diameter was 10mm. Mean operative time was 136±12 minutes (118-160) where as the median operative time was 133.5 minutes. The pearson correlation coefficient between Operative time and MPD was 0.043 (p<0.05) which suggest that the patients with thinner MPD had longer operative time [Table/Fig-2].

Illustrating the relation of MPD with Operative time.

Out of the 33 patients 48.5% of patient needed intraoperative blood transfusion (median 1 unit). All the patients were kept in intensive care unit in the early postoperative period. 4 out of 33 patients (12.1%) had surgical complications mainly wound infection (2), pancreatic leak (1) and abdominal abscess (1). No patient had undergone reoperation for the complications. In our study, thirty day mortality rate was zero.

The mean scores (with standard error) of VAS and different domains in the preoperative period and during postoperative follow up at 3, 6, 12, 18, 24, 30 and 36 months as calculated by EORTC QLQ-C30(3) questionnaire is given in the [Table/Fig-3]. Mean VAS scores at different time periods were 81.5, 4.54, 4.54 5.15, 3.21, 7.81, 10.76, and 22.0 [Table/Fig-4]. For PFD the mean values were 32.06, 12.76, 13.09, 15.87,16.57, 17.76, and 15.60. For PD the mean values were 37.85, 14.09, 14.21, 15.15, 16.09, 17.95, 20.54, and 20.40. For ED the mean values were 15.18, 6.06, 6.36, 6.81, 7.65, 8.15, 9.00, and 8.20. For SD the mean values were 8.63, 3.93, 4.42, 4.54, 5.09, 5.47, 6.38, and 7.20. For GH the mean values were 4.48, 12.54, 12.57, 12.03, 11.65, 10.78, 10.00, and 10.20 [Table/Fig-5a,b,c,d and e].

Tabulation of the mean preoperative and postoperative follow up VAS score, Physical functional domain (PFD) score, Physical domain (PD) score, Emotional domain (ED) score, Social domain (SD) score and Global health (GH) score of the patients.

TimeVAS (mean ±s.e.)PFD (mean ±s.e.)PD (mean ±s.e)ED (mean ±s.e)SD (mean ±s.e)GH (mean ±s.e)
Preoperative81.51±10.032.06±0.4037.85±0.3615.18±0.328.63±0.314.48±0.26
3 months(n=33)4.54±6.612.76±0.4914.09±0.366.06±0.243.93±0.1812.54±0.32
6 months(n=33)4.54±6.513.09±0.5214.21±0.526.36±0.274.42±0.2512.57±0.30
12 months(n=33)5.15±6.513.67±0.6315.15±0.596.81±0.424.54±0.2712.03±0.33
18 months(n=32)3.21±5.815.87±0.7516.09±0.817.65±0.505.09±0.3011.65±0.35
24 months (n=19)7.81±10.816.57±1.0817.95±1.158.15±0.695.47±0.4110.78±0.54
30 months(n=13)10.76±10.317.76±1.5620.54±1.499.00±0.916.38 ±0.5210.00±0.63
36 months (n=5)22.0 ±14.815.60±2.7820.40±3.658.20±1.497.20±1.3510.20±0.80

[n= number of patients, s.e.= standard error] VAS: visual analogue scale


Illustrating the mean visual analogue scale scores (VAS) both during the preoperative period and the follow up period. [M: Month].

Illustrating the mean physical functional domain (PFD) scores according to QLQ-C30 (3) both during the preoperative period and the follow up period. [M: Month].

Illustrating the mean physical domain (PD) scores of the patients according to QLQ-C30 (3) both during the preoperative period and the follow up period. [M: Month].

Illustrating the mean emotional domain (ED) scores of the patients according to QLQ-C30 (3) both during the preoperative period and the follow up period. [M: Month].

Illustrating the mean social domain (SD) scores of the patients according to QLQ-C30 (3) both during the preoperative period and the follow up period. [M: Month].

Illustrating the mean global health (GH) scores of the patients according to QLQ- C30 (3) both during the preoperative period and the follow up period. [M: Month].

ANOVA showed that there was significant difference in the mean VAS scores (p<0.001), PFD score (p<0.0001), PD score (p<0.001), ED score (p<0.0001), SD score (p<0.001) and GH score (p<0.0001) during different time period as compared to preoperative mean score. As per the Critical Difference the mean scores of PFD, PD, SD and ED decreased significantly in different months compared to preoperative value except for SD during 30th and 36th month at which no significant difference was observed [Table/Fig-5a-d,6]. This is probably due to loss to follow up of the patients during this period (n=13, n=5). However, as per the critical difference the mean score of GH increased significantly in different months compared to preoperative mean score [Table/Fig- 5e,6].

Comparison between preoperative (PO) mean values of different domains of QLQ-C30(3) with their follow up values.

Comparison between preoperative(PO) mean value of PFD score with the follow-up valuesDifference of meanSignificance
PO Vs 3rd Month19.3p<0.0001 S
PO Vs 6th Month18.97p<0.0001 S
PO Vs 12th Month18.39p<0.0001 S
PO Vs 18th Month16.19p<0.001 S
PO Vs 24th Month15.49p<0.001 S
PO Vs 30th Month14.3p<0.001 S
PO Vs 36th Month16.46p<0.001 S
Comparison between preoperative(PO) mean value of PD score with the follow-up valuesDifference of meanSignificance
PO Vs 3rd Month23.76p<0.0001 S
PO Vs 6th Month23.64p<0.0001 S
PO Vs 12th Month22.7p<0.0001 S
PO Vs 18th Month21.76p<0.001 S
PO Vs 24th Month19.9p<0.001 S
PO Vs 30th Month17.31p<0.001 S
PO Vs 36th Month17.45p<0.001 S
Comparison between preoperative(PO) mean value of ED score with the follow-up valuesDifference of meanSignificance
PO Vs 3rd Month9.12p<0.001 S
PO Vs 6th Month8.82p<0.001 S
PO Vs 12th Month8.37p<0.001 S
PO Vs 18th Month7.53p<0.001 S
PO Vs 24th Month7.03p<0.01 S
PO Vs 30th Month6.18p<0.01 S
PO Vs 36th Month6.98p<0.01 S
Comparison between preoperative(PO) mean value of SD score with the follow-up valuesDifference of meanSignificance
PO Vs 3rd Month4.7p<0.0001 S
PO Vs 6th Month4.21p<0.0001 S
PO Vs 12th Month4.09p<0.0001 S
PO Vs 18th Month3.54p<0.001 S
PO Vs 24th Month3.16p<0.05 S
PO Vs 30th Month2.25p>0.05 NS
PO Vs 36th Month1.43p>0.05 NS
Comparison between preoperative(PO) mean value of GH score with the follow-up valuesDifference of meanSignificance
PO Vs 3rd Month8.06p<0.0001 S
PO Vs 6th Month8.09p<0.0001 S
PO Vs 12th Month7.55p<0.0001 S
PO Vs 18th Month7.17p<0.001 S
PO Vs 24th Month6.30p<0.001 S
PO Vs 30th Month5.52p<0.01 S
PO Vs 36th Month5.72p<0.01 S

[S: Significant, NS: Not significant, PO: Preoperative, PFD: Physical function domain, PD: Physical domain, ED: Emotional domain, SD: Social domain, GH: General health]


Discussion

Chronic pancreatitis (CP) is a disease that is mostly seen in chronic alcoholics; however tropical pancreatitis a form of CP is frequently seen in tropical counties like India. We found a different variety of CP (tropical pancreatitis) mostly affecting malnourished younger individuals [5]. Debilitating pain and pancreatic insufficiency (exocrine and endocrine insufficiency) are characteristics of CP [26]. Efforts to relieve this debilitating pain should be individualized based on the size of the duct and the location of the disease. In our study we have seen that the operative time taken for operating patients with larger main pancreatic duct is significantly less when compared with thinner duct patients.

Pancreaticoduodenectomy is the standard procedure for addressing patients of CP with disease limited to the head region. Farkas and colleagues have shown better outcomes of organ preserving pancreatic head resection compared to pancreaticoduodenectomy interms of increased postoperative morbidity, longer hospital stay, longer operative time and lower quality of life [27]. Organ preserving procedures proposed by Beger and Frey are now a day’s more popular among the pancreatic surgeons than the respective procedures, because it combines the feature of resection as well as drainage. Izbicki and Bloeche have shown in their study that Frey procedure is a “patient friendly” procedure and has zero mortality and a low morbidity rate [28]. Our mortality and morbidity (12.1%) rates associated with the procedure are well within the acceptable range. Major postoperative complications in the current series include pancreatic leakage which was managed conservatively. In a recent meta-analysis done by Zhou Y et al., involving 23 studies comprising of 800 patients found that Frey procedure had favorable outcomes in terms of operation time, blood transfusion, overall morbidity, length of hospital and intensive care unit stay, pancreatic function and quality of life as compared to pancreaticoduodenectomy and Beger procedure [18].

CP is an incurable progressive inflammatory disease of pancreas. Therefore the aim of any surgical intervention in patients with CP is to improve the quality of life, of the patient along with relief from abdominal pain. Studies have shown that 70-80% of the patient, who underwent Frey procedure, had good pain relief [2932] and improved quality of life [18,29]. In our series all the patients have significant improvement in pain and in all domains excepting for the last two follow up values in social domain, which may be due to patients lost to follow up. This observation further confirmed that the Freys’ procedure does improve the quality of life as shown by other studies.

Preservation of already limited functionality of the pancreas, occupational rehabilitation and increase in quality of life following surgery should be used in the evaluation of therapeutic success of any surgical procedure done for CP [18,33,34]. Collection of data on quality of life should be done with the help of standardized questionnaires so that effective comparison of different surgical procedures for CP is possible.

Limitation

Small sample size and short duration of follow up are the limitations of this study. We used EORTC QLQ-C30 (version 3) Questionnaire as an instrument for quality of life assessment in our study which is a general health questionnaire used for cancer patient and is not specific for CP. We have categorized all the 30 questions of the questionnaire into five domain i.e. physical function domain, physical domain, emotional domain, social domain and global health score to make the analysis simple and easy to interpret.

Conclusion

Quality of life has always been the most important decisive factor for patients with CP. The patients usually have debilitating abdominal pain and depend on chronic opioid analgesics. Freys’ procedure helps in ductal decompression along with resection of the “pacemaker of pain”, that is the head of the pancreas, with excellent outcome when compared with other surgical techniques. It improves quality of life and gives the patient long term relief from pain and suffering. We recommend Frey procedure as a standard method of therapy for chronic pancreatitis. This method is easier, organ-preserving and associated with minimal mortality and morbidity.

Disclosure: We don’t have any financial support for publication of this study.

Appendix 1: EORTC QLQ-C30 (Version 3)

We are interested in some things about you and your health. Please answer all of the questions yourself by circling the number that best applies to you. There is no "right" or "wrong" answers. The information that you provide will remain strictly confidential.

Please fill in your initials:

Your birth date (Day, Month, and Year):

Today’s date (Day, Month, Year):

Not at AllA LittleQuite a BitVery Much
1. Do you have any trouble doing strenuous activities, like carrying a heavy shopping bag or a suitcase?1234
2. Do you have any trouble taking a long walk?1234
3. Do you have any trouble taking a short walk outside of the house?1234
4. Do you need to stay in bed or a chair during the day?1234
5. Do you need help with eating, dressing, washing yourself or using the toilet?1234
During the past week:Not at AllA LittleQuite a BitVery Much
6. Were you limited in doing either your work or other daily activities?1234
7. Were you limited in pursuing your hobbies or other leisure time activities?1234
8. Were you short of breath?1234
9. Have you had pain?1234
10. Did you need to rest?1234
11. Have you had trouble sleeping?1234
12. Have you felt weak?1234
13. Have you lacked appetite?1234
14. Have you felt nauseated?1234
15. Have you vomited?1234
16. Have you been constipated?1234
During the past week:Not at AllA LittleQuite a BitVery Much
17. Have you had diarrhea?1234
18. Were you tired?1234
19. Did pain interfere with your daily activities?1234
20. Have you had difficulty in concentrating on things, like reading a newspaper or watching television?1234
21. Did you feel tense?1234
22. Did you worry?1234
23. Did you feel irritable?1234
24. Did you feel depressed?1234
25. Have you had difficulty remembering things?1234
26. Has your physical condition or medical treatment interfered with your family life?1234
27. Has your physical condition or medical treatment interfered with your social activities?1234
28. Has your physical condition or medical treatment caused you financial difficulties?1234

For the following questions please circle the number between 1 and 7 that best applies to you

29. How would you rate your overall health during the past week?

1234567
Very poorExcellent

30. How would you rate your overall quality of life during the past week?

1234567
Very poorExcellent

Appendix 2 Classification of the 30 questions of EORTC QLQ-C30 (3) questionnaire into five domains

DomainItem(Question) numbersScores(min-max)
Physical functional domain(PFD)1-7, 11 and 139-22
Physical domain(PD)8-10, 12, 14-1910-40
Emotional domain(ED)20-256-24
Social domain(SD)26-283-12
Global health (GH)29-302-14

BMI: Body Mass Index[n= number of patients, s.e.= standard error] VAS: visual analogue scale[S: Significant, NS: Not significant, PO: Preoperative, PFD: Physical function domain, PD: Physical domain, ED: Emotional domain, SD: Social domain, GH: General health]

References

[1]Roch A, Teyssedou J, Mutter D, Marescaux J, Pessaux P, Chronic pancreatitis: A surgical disease? Role of the Frey procedure World J Gastrointest Surg 2014 6(7):129-35.  [Google Scholar]

[2]Ni Q, Yun L, Roy M, Shang D, Advances in surgical treatment of chronic Pancreatitis World Journal of Surgical Oncology 2015 13:34  [Google Scholar]

[3]Evans JD, Wilson PG, Carver C, Bramhall SR, Buckels JA, Mayer AD, Outcome of surgery for chronic pancreatitis Br J Surg 1997 84:624-29.  [Google Scholar]

[4]Secknus R, Mossner J, Changes in incidence and prevalence of acute and chronic pancreatitis in Germany Chirurg 2000 71:249-52.  [Google Scholar]

[5]Tandon RK, Sato N, Garg PK, Chronic pancreatitis: Asia-Pacific consensus report J Gastroenterol Hepatol 2002 17:508-18.  [Google Scholar]

[6]Balliet WE, Edwards-Hampton S, Borckardt JJ, Morgan K, Adams D, Owczarski S, Depressive symptoms, pain, and quality of life among patients with nonalcohol-related chronic pancreatitis Pain research and treatment 2012 2012:978646  [Google Scholar]

[7]Fitzsimmons D, Kahl S, Butturini G, Symptoms and quality of life in chronic pancreatitis assessed by structured interview and the EORTC QLQ-C30 and QLQ-PAN26 Am J Gastroenterol 2005 100(4):918-26.  [Google Scholar]

[8]Amann ST, Yadav D, Barmada MM, Physical and mental quality of life in chronic pancreatitis: a case-control study from the North American Pancreatitis Study 2 cohort Pancreas 2013 42(2):293-300.  [Google Scholar]

[9]Di Sebastiano P, The quality of life in chronic pancreatitis: the role of surgery JOP 2006 7:120-21.  [Google Scholar]

[10]Van Esch AA, Wilder-Smith OH, Jansen JB, van Goor H, Drenth JP, Pharmacological management of pain in chronic pancreatitis Dig Liver Dis 2006 38:518-26.  [Google Scholar]

[11]Lankisch PG, Lohr-Happe A, Otto J, Creutzfeldt W, Natural course in chronic pancreatitis: pain, exocrine and endocrine pancreatic insufficiency and prognosis of the disease Digestion 1993 54:148-55.  [Google Scholar]

[12]Traverso LW, Kozarek RA, Pancreaticoduodenectomy for chronic pancreatitis Ann surg 1999 236:429-36.  [Google Scholar]

[13]Traverso LW, The surgical management of chronic pancreatitis: the Whipple procedure Adv Surg 1999 32:23-39.  [Google Scholar]

[14]Beger HG, Witte C, Krutezberger W, Bittner R, Experience with duodenum-sparing pancreas head resection in chronic pancreatitis Chirurg 1980 51:303-07.  [Google Scholar]

[15]Frey CF, The surgical management of chronic pancreatitis: the frey procedure Adv surg 1999 32:41-85.  [Google Scholar]

[16]Frey CF, Smith GJ, Description and rationale of a new operation for chronic pancreatitis Pancreas 1987 2:701-07.  [Google Scholar]

[17]Vasile D, Ilco A, Popa D, Belega A, Pana S, The surgical treatment of chronic pancreatitis: a clinical series of 17 cases Chirurgia (Bucur) 2013 108:794-99.  [Google Scholar]

[18]Zhou Y, Shi B, Wu L, Wu X, Li Y, Frey procedure for chronic pancreatitis: Evidence-based assessment of short- and long-term results in comparison to pancreatoduodenectomy and Beger procedure: A meta-analysis Pancreatology 2015 15(4):372-79.  [Google Scholar]

[19]Ueda J, Miyasaka Y, Ohtsuka T, Takahata S, Tanaka M, Short- and long-term results of the Frey procedure for chronic pancreatitis J Hepatobiliary Pancreat Sci 2015 22(3):211-16.  [Google Scholar]

[20]Tanaka M, Matsumoto I, Shinzeki M, Short- and long-term results of modified Frey’s procedure in patients with chronic pancreatitis: a retrospective Japanese single-center study Kobe J Med Sci 2014 60(2):E30-36.  [Google Scholar]

[21]Amudhan A, Balachandar TG, Kannan DG, Factors affecting outcome after Frey procedure for chronic pancreatitis HPB : The Official Journal of the International Hepato Pancreato Biliary Association 2008 10(6):477-82.  [Google Scholar]

[22]Negi S, Singh A, Chaudhary A, Pain relief after Frey’s procedure for chronic pancreatitis Br J Surg 2010 97(7):1087-95.  [Google Scholar]

[23]Pappas SG, Pilgrim CC, Keim R, The Frey Procedure for Chronic Pancreatitis Secondary to Pancreas Divisum JAMA Surg 2013 148(11):1057-62.  [Google Scholar]

[24]Burckhardt CS, Jones KD, Adult measures of pain: The McGill Pain Questionnaire (MPQ), Rheumatoid Arthritis Pain Scale (RAPS), ShortForm McGill Pain Questionnaire (SF-MPQ), Verbal Descriptive Scale (VDS), Visual Analog Scale (VAS), and West Haven-Yale Multidisciplinary Pain Inventory (WHYMPI) Arthritis Rheum 2003 49:S96-104.  [Google Scholar]

[25]Chien T-W, Lin S-J, Wang W-C, Leung HW, Lai W-P, Chan AL, Reliability of 95% confidence interval revealed by expected quality-of-life scores: an example of nasopharyngeal carcinoma patients after radiotherapy using EORTC QLQ-C 30 Health and Quality of Life Outcomes 2010 8:68  [Google Scholar]

[26]Braganza JM, Lee SH, McCloy RF, McMahon MJ, Chronic pancreatitis Lancet 2011 377:1184-97.  [Google Scholar]

[27]Farkas G, Leinder L, Daeoczi Prospective randomized comparison of organ_preserving pancreatic head resection with pylorus preserving pancreaticoduodenectomy Langenbecks Arch Surg 2006 391:338-42.  [Google Scholar]

[28]Izbicki JR, Bloeche C, Drainage operation as therapeutic principle of surgical organ saving treatment of chronic pancreatitis Chirurug 1997 68(9):865-73.  [Google Scholar]

[29]Pessaux P, Kianmanesh R, Regimbeau JM, Frey procedure in the treatment of chronic pancreatitis: short-term results Pancreas 2006 33(4):354-58.  [Google Scholar]

[30]Frey CF, Amikura K, Local resection of the head of the pancreas combined with longitudinal pancreaticojejunostomy in the management of patients with chronic pancreatitis Ann Surg 1994 220:492-507.  [Google Scholar]

[31]Keus E, van Laarhoven CJ, Eddes EH, Size of the pancreatic head as a prognostic factor for the outcome of Beger’s procedure for painful chronic pancreatitis Br J Surg 2003 90(3):320-24.  [Google Scholar]

[32]Aimoto t, Uchida E, Matsushita A, Kawano Y, Mizutani S, Kobayashi T, Long-term outcomes after Frey’s Procedure for chronic pancreatitis with an inflammatory mass of the pancreatic head, with special reference to locoregional complications J Nippon Med Sch 2013 80(2):148-54.  [Google Scholar]

[33]Falconi M, Bassi C, Casetti L, Mantovani W, Mascetta G, Sartori N, Long term results of Frey’s procedure for chronic pancreatitis: a longitudinal prospective study on 40 patients J Gastrointest surg 2006 10(4):504-10.  [Google Scholar]

[34]Bloechle C, Izbicki JR, Knoefel WT, Kuechler T, Broelsch CE, Quality of Life in Chronic Pancreatitis - Results After Duodenum- Preserving Resection of the Head of the Pancreas Panceas 1995 11:77-85.  [Google Scholar]